TNDM Tandem Diabetes Care: Operating Margin

Corporate emblem and logo of Tandem Corp (TNDM)

Opening the chart on GURU.Markets, we observe that the operational efficiency of Tandem Diabetes Care (TNDM) is shielded from market volatility due to stable demand for diabetes treatment, with the value holding at -2.40. Recurring payments for pump consumables guarantee predictable cash flows. Growth prospects are driven by the implementation of Control-IQ AI algorithms, the launch of the compact Mobi model, and expansion into global markets.

TNDM: Tandem Diabetes Care, Inc. Operating Margin 07/04/2022 - 11/20/2026

Tandem Diabetes Care - analytical breakdowns and key metrics (TNDM)

- share price and consensus valuation forecast:
Fundamental company analysis:TNDM, Tandem Diabetes Care Inc
Brand item of Tandem Corp

Tandem Diabetes Care (TNDM) demonstrates high operational resilience due to the humanitarian status of its products. This metric is calculated as the ratio of operating profit to revenue, measuring cost management efficiency before accounting for financial obligations. Investors use this metric to assess the business's ability to scale profits amid stable electronics supplies. The absence of sanctions risks minimizes cost volatility. An analysis of operating margin fluctuations confirms the fundamental strength of the model.

Competitors of Tandem Diabetes Care (TNDM)

BSX (Boston Scientific Corporation Inc.) - Operating Margin|Operating Margin Edwards Lifesciences Inc.|Operating Margin RMD|Operating Sales Margin Insulet Corporation PODD|Operating Profitability Zimmer Biomet ZBH|CooperVision - Operating Profitability|ALGN - Operating Profitability|GMED: Operating Profitability|TMDX (TransMedics Corp) - Operating Sales Margin|Alphatec Holdings, Inc. - Operating Profit Rate|AORT (Artivion Corp) - Operating Margin|Operating Return on Sales Enovis Corp ENOV|Operating Profitability Integra LifeSciences Corp (IART)|Establishment Labs (ESTA) - Operating Profitability Margin|iLet Bionic Pancreas - Operating Sales Margin|Operating Margin IRADIMED CORPORATION IRMD|Embecta Corp - Operating Margin|Profitability of Operations AxoGen Inc AXGN|SI-BONE (SIBN) - Operating Profitability|Operating Profit Margin OFIX (Orthofix Corp)|BVS (Bioventus Inc) - Operating Margin|Operating Sales Margin OrthoPediatrics Corp. (KIDS)|Operating Margin TMCI|SRTA - Operating Return on Sales|Operating Profitability Carlsmed Inc CARL|RXST: Return on Sales by Operating Profit|CLPT: Operating Sales Margin|stereotaxis.com - Operating Profit Ratio|NeuroStar (STIM) - Operating Profitability|SGHT - Profitability of Operations|Operating Profitability Orchestra BioMed|Return on Sales by Operating Profit ANIK (Anika Therapeutics)|Operating Profitability inspiremd.com (NSPR)|Jin Medical International Ltd - Return on Sales by Operating Profit|Operating Margin VANI (Vivani Medical Inc)|XTNT: Return on Sales by Operating Profit|NMTC - Operating Profitability|MODD: Operating Profitability|MYO: Operating Margin|envoymedical.com - Operating Profit Rate|Operating Sales Margin VVOS|Operating Return on Sales enVVeno NVNO|Operating Margin SINT|TNON - Operating Return on Sales|Operating Profitability ReWalk Robotics LFWD|AMIX: Return on Sales by Operating Profit|IVF - Operating Profitability|Operating Return on Sales Bone Biologics Corp|AXNX: Operating Margin|Operating Sales Margin BIOLASE, Inc.|Operating Sales Margin DYNT|Operating Sales Margin Paragon 28 (FNA)|Operating Profitability INVO Bio (INVO)